rheumatoid arthritis

Protalex Initiates Enrollment of Phase I/II Continuation Trial of PRTX-100 in Active Rheumatoid Arthritis Patients
Yahoo
Fri, 03/13/15 - 09:42 am
Protalex
rheumatoid arthritis
PRTX-100
clinical trials
FDA postpones key hearing on biosimilar copy of blockbuster drug
Yahoo/Reuters
Thu, 02/26/15 - 09:55 am
FDA
biosimilars
Rensima
Remicade
JNJ
rheumatoid arthritis
Crohn's Disease
Hospira
Celltrion
Amgen: Study shows its biosimilar version of popular arthritis drug Humira about as effective
Yahoo/AP
Wed, 02/4/15 - 08:25 am
Amgen
biosimilar
Humira
rheumatoid arthritis
J&J teams with U.K. to probe molecular causes of RA drug failures
Fierce Biotech
Tue, 02/3/15 - 10:41 am
JNJ
UK
rheumatoid arthritis
Janssen
R&D
Infinity to Stop Development on Rheumatoid Arthritis Treatment
WSJ Online
Thu, 01/8/15 - 07:56 am
Infinity Pharmaceuticals
rheumatoid arthritis
duvelisib
AbbVie Has Some Excellent Entries In Rheumatoid Arthritis
Seeking Alpha
Fri, 01/2/15 - 07:35 pm
AbbVie
rheumatoid arthritis
ABT-494
ABT-122
ALX-0061
Tregalizumab
Lilly Rheumatoid Arthritis Drug Meets Goals in Final-Stage Trial
Bloomberg
Tue, 12/9/14 - 08:08 am
Eli Lilly
rheumatoid arthritis
baricitinib
J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
Fierce Biotech
Tue, 12/2/14 - 09:25 am
JNJ
Astellas
rheumatoid arthritis
ASP015K
JAK inhibitors
Roche's RoACTEMRA To Go Up Against Anti-Rheumatoid Arthritis Drugs From Bristol-Myers, AbbVie
Bidness Etc.
Mon, 09/8/14 - 12:29 pm
Roche
rheumatoid arthritis
RoActemra
AbbVie
Bristol-Myers Squibb
Bristol-Myers dumps $1B-plus Alder deal, punts rheumatoid arthritis drug
Fierce Biotech
Tue, 09/2/14 - 11:21 am
Bristol-Myers Squibb
Alder Biopharma
rheumatoid arthritis
clazakizumab
Humira Still Key to AbbVie
Motley Fool
Sat, 07/26/14 - 10:10 am
AbbVie
Humira
psoriasis
Chron's Disease
rheumatoid arthritis
Pfizer Arthritis drug leads to full head of hair
CNBC
Mon, 06/23/14 - 09:40 am
Pfizer
alopecia
rheumatoid arthritis
Xeljanz
Pfizer XELJANZ Phase 3 findings support safety, efficacy
Yahoo/Fly on the Wall
Wed, 06/18/14 - 05:39 pm
Pfizer
Xeljanz
rheumatoid arthritis
Sanofi, Regeneron announce new data from positive sarilumab Phase 3 trial
The Fly on the Wall
Thu, 06/12/14 - 09:22 am
Sanofi
Regeneron
Sarilumab
rheumatoid arthritis
AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints
The Fly on the Wall
Mon, 05/12/14 - 11:51 am
mavrilimumab
sifalimumab
AstraZeneca
MedImmune
lupus
autoimmune disease
rheumatoid arthritis
AbbVie's Humira Still a Growth Engine
Motley Fool
Sun, 03/9/14 - 01:35 pm
AbbVie
Humira
rheumatoid arthritis
psoriasis
Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study
Bloomberg
Fri, 11/22/13 - 08:15 am
Sanofi
Regeneron
rheumatoid arthritis
Sarilumab
Horizon obtains US rights to arthritis drug Vimovo
Yahoo/AP
Tue, 11/19/13 - 07:59 am
vivmo
Horizon Pharma
osteoarthritis
rheumatoid arthritis
BMS rheumatoid arthritis drug clazakizumab causes a stir at ACR
Pharma Times, UK
Tue, 10/29/13 - 12:14 pm
rheumatoid arthritis
clazakizumab
Bristol-Myers Squibb
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Clovis Oncology
Synta
Incyte
CO-1686
non-small cell lung cancer
ganetespib
INCB39110
rheumatoid arthritis

Pages